𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemical Synthesis of Galantamine, an Acetylcholinesterase Inhibitor for Treatment of Alzheimer′s Disease

✍ Scribed by Jose Marco-Contelles; Carolina Rodriguez; Antonio G. Garcia

Publisher
John Wiley and Sons
Year
2006
Weight
8 KB
Volume
37
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of galantamine treatment on
The effects of galantamine treatment on caregiver time in Alzheimer's disease
✍ Mary Sano; Gordon K. Wilcock; Bart van Baelen; Shane Kavanagh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Abstract ## Aim The aim of the study was to determine whether the clinical benefits of galantamine for patients with Alzheimer's disease lead to benefits for caregivers. ## Methods Data were pooled from two concurrent, multi‐centre, randomized, double‐blind, placebo‐controlled, 6‐month trials

The efficacy of galantamine in the treat
The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure
✍ J. E. Mintzer; P. Kershaw 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 2 views

## Abstract ## Background Acetylcholinesterase inhibitors (AChEIs) can provide benefits at the cognitive, behavioral, and functional levels to patients with Alzheimer's disease (AD). With more AChEIs now available, treatment considerations may include whether the patient has had prior exposure to

Assessment of health economics in Alzhei
Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK
✍ A. Ward; J. J. Caro; D. Getsios; K. Ishak; J. O'Brien; R. Bullock 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

## Abstract ## Objective To assess the long‐term health and economic impact of treating mild to moderate Alzheimer's disease (AD) with galantamine (16 mg or 24 mg per day) compared to no cholinesterase therapy in the UK. ## Methods The long‐term costs and outcomes were assessed using a model dev